ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly
Authors:
- Tommaso SelmiTSTommaso Selmi
- Claudia AlecciCAClaudia Alecci
- Miriam Dell’ AquilaMAMiriam Dell’ Aquila
- Lucia MontorsiLMLucia Montorsi
- Andrea MartelloAMAndrea Martello
- Filippo GuizzettiFGFilippo Guizzetti
- Nicola VolpiNVNicola Volpi
- Sandra ParentiSPSandra Parenti
- Sergio FerrariSFSergio Ferrari
- Paolo SalomoniPSPaolo Salomoni
- Alexis GrandeAGAlexis Grande
- Tommaso Zanocco-MaraniTZTommaso Zanocco-Marani
Open Access
- 6 May 2015
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 1-7
Abstract
ZFP36 is an mRNA binding protein that exerts anti-tumor activity in glioblastoma by triggering cell death, associated to an increase in the stability of the kinase RIP1. We used cell death assays, size exclusion chromatography, Co-Immunoprecipitation, shRNA lentivectors and glioma neural stem cells to determine the effects of ZFP36 on the assembly of a death complex containing RIP1 and on the induction of necroptosis. Here we demonstrate that ZFP36 promotes the assembly of the death complex called Ripoptosome and induces RIP1-dependent death. This involves the depletion of the ubiquitine ligases cIAP2 and XIAP and leads to the association of RIP1 to caspase-8 and FADD. Moreover, we show that ZFP36 controls RIP1 levels in glioma neural stem cell lines. We provide a molecular mechanism for the tumor suppressor role of ZFP36, and the first evidence for Ripoptosome assembly following ZFP36 expression. These findings suggest that ZFP36 plays an important role in RIP1-dependent cell death in conditions where IAPs are depleted.Keywords
This publication has 25 references indexed in Scilit:
- Glioblastoma-Initiating Cells: Relationship with Neural Stem Cells and the Micro-EnvironmentCancers, 2013
- The roles of FADD in extrinsic apoptosis and necroptosisBMB Reports, 2012
- The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPsMolecular Cell, 2011
- Functional complementation between FADD and RIP1 in embryos and lymphocytesNature, 2011
- Tristetraprolin controls the stability of cIAP2 mRNA through binding to the 3′UTR of cIAP2 mRNABiochemical and Biophysical Research Communications, 2010
- Tristetraprolin Impairs NF-κB/p65 Nuclear TranslocationJournal of Biological Chemistry, 2009
- Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic ScreensCell Stem Cell, 2009
- RIP1, a kinase on the crossroads of a cell's decision to live or dieCell Death & Differentiation, 2007
- A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNAOncogene, 2003
- Roles of tumor necrosis factor-α receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndromeBlood, 2001